All In MedTech

Device Trial Radar · NCT05073510

Clinical Evaluation of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease

A Prospective, Multicenter, Nonrandomized, Open-label, Single-arm Study of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease

Last checked: Nov 20, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

187

Actual

Start

Oct 11, 2021

Primary completion

Sep 11, 2023

Study completion Sep 11, 2023

Sponsor

Lead sponsor
BlueDop Medical LTDNot on our public-company list
Sponsor type
Industry
Collaborators
AKRN Scientific Consulting, S.L.
First posted
Oct 11, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a BlueDop Vascular Expert System (BVE) Post-Market Clinical Follow-Up (PMCF) study. The primary objective of the study is to assess the clinical applicability and diagnostic accuracy of the BVE device in subjects who require an arterial duplex test due to suspected peripheral arterial disease (PAD).

Conditions

  • Peripheral Arterial Disease

Interventions

  • BVEDevice

    Participants will undergo BVE evaluation for assessing Peripheral Arterial Disease (PAD)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determination of Presence or Absence of Significant PAD With BVE and Arterial DuplexTime frame: 1 day

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Clínica Universidad de Navarra

    Madrid, Spain

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.